Back to Search Start Over

Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study.

Authors :
Luo, J.‐C.
Leu, H.‐B.
Hou, M.‐C.
Huang, C.‐C.
Lin, H.‐C.
Lee, F.‐Y.
Chang, F.‐Y.
Chan, W.‐L.
Lin, S.‐J.
Chen, J.‐W.
Source :
Alimentary Pharmacology & Therapeutics; Sep2012, Vol. 36 Issue 6, p542-550, 9p, 5 Charts, 1 Graph
Publication Year :
2012

Abstract

Background Few large population-based studies have compared the occurrence of peptic ulcer bleeding ( PUB) in cirrhotic and noncirrhotic patients. Aims To investigate if cirrhotic patients have higher risk of PUB than the general population and to identify possible risk factors of PUB in cirrhotic patients. Methods Using the National Health Insurance Research Database, a nationwide population-based dataset in Taiwan and matching age, gender, comorbidities and ulcerogenic medication by propensity score, 4013 cirrhotic patients, 8013 chronic hepatitis patients and 7793 normal controls were compared. The log-rank test was used to analyse differences in accumulated PUB-free survival rates between the groups. Cox proportional hazard regressions were performed to evaluate independent risk factors for PUB in all patients and identified risk factors of PUB in cirrhotic patients. Results During the 7-year follow-up, cirrhotic patients had significantly higher incidences of PUB than chronic hepatitis patients and controls, respectively ( P < 0.001 by log-rank test). By Cox proportional hazard regression analysis, cirrhosis was independently associated with increased risk of PUB (hazard ratio: 4.22; 95% CI 3.37-5.29, P < 0.001) after adjusting for age, gender, economic status, underlying comorbidities and ulcerogenic medication. Age, male, diabetes, chronic renal disease, history of gastro-oesophageal variceal bleeding and use of nonsteroidal anti-inflammatory drugs were risk factors for PUB in cirrhotic patients. Conclusion Cirrhotic patients have a significantly higher risk of peptic ulcer bleeding after adjustments for possible confounding factors like age, gender, economic status, underlying comorbidities and ulcerogenic medication. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
02692813
Volume :
36
Issue :
6
Database :
Complementary Index
Journal :
Alimentary Pharmacology & Therapeutics
Publication Type :
Academic Journal
Accession number :
79294676
Full Text :
https://doi.org/10.1111/j.1365-2036.2012.05225.x